While advances in drug development have accelerated dramatically in recent years, pharmaceutical manufacturing processes have struggled to keep pace – for a number of intertwined reasons. And AI ...

Many investors are concerned about valuations in U.S. stocks as well as fears of a looming economic slowdown brought on by the government shutdown, weak job growth and inflation. But the best growth ...